ZANOSAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zanosar, and when can generic versions of Zanosar launch?
Zanosar is a drug marketed by Teva Pharms Usa and is included in one NDA.
The generic ingredient in ZANOSAR is streptozocin. One supplier is listed for this compound. Additional details are available on the streptozocin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZANOSAR?
- What are the global sales for ZANOSAR?
- What is Average Wholesale Price for ZANOSAR?
Summary for ZANOSAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 28 |
| Patent Applications: | 35 |
| Drug Prices: | Drug price information for ZANOSAR |
| What excipients (inactive ingredients) are in ZANOSAR? | ZANOSAR excipients list |
| DailyMed Link: | ZANOSAR at DailyMed |
Pharmacology for ZANOSAR
| Drug Class | Alkylating Drug |
| Mechanism of Action | Alkylating Activity |
US Patents and Regulatory Information for ZANOSAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms Usa | ZANOSAR | streptozocin | INJECTABLE;INJECTION | 050577-001 | May 7, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
